Acadia Pharmaceuticals | ACAD - Interest Expense On Debt

Stock Price
24.49
Daily Change
-1.64 -6.28%
Monthly
-6.35%
Yearly
30.75%
Q1 Forecast
24.36

Acadia Pharmaceuticals reported $0 in Interest Expense on Debt for its fiscal quarter ending in September of 2024.





Interest Expense On Debt Change Date
Acadia Pharmaceuticals USD 0 4.12M Sep/2024
ALKERMES USD 4.65M 1.35M Dec/2024
Alnylam Pharmaceuticals USD 44.4M 4.15M Sep/2025
Biogen USD 72.6M 12.6M Jun/2025
BioMarin Pharmaceutical USD 2.58M 100K Sep/2025
Bristol-Myers Squibb USD 480M 5M Sep/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Cytokinetics USD 26.32M 2.06M Sep/2025
Eisai JPY 1.44B 526M Sep/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
Incyte USD 592K 2K Sep/2025
J&J USD 18M 290M Sep/2025
Moderna USD 12.14B 12.13B Sep/2025
Neurocrine Biosciences USD 1.1M 0 Mar/2024
Pfizer USD 652M 2M Sep/2025
Prothena USD 352.63M 46.44M Sep/2025
PTC Therapeutics USD 2.64B 2.61B Sep/2025
Sarepta Therapeutics USD 7.56M 2.33M Sep/2025
Ultragenyx Pharmaceutical USD 14.15M 108K Sep/2025
Vertex Pharmaceuticals USD 3.3M 400K Sep/2025